Publications en collaboration avec des chercheurs de Hospital Universitari de Bellvitge (38)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Cognitive impairment and dementia in young onset Parkinson’s disease

    Journal of Neurology, Vol. 270, Núm. 12, pp. 5793-5812

  3. Epidemiology of ataxia and hereditary spastic paraplegia in Spain: a cross-sectional study

    Neurologia, Vol. 38, Núm. 6, pp. 379-386

  4. Risk of Cognitive Impairment in Patients With Parkinson’s Disease With Visual Hallucinations and Subjective Cognitive Complaints

    Journal of Clinical Neurology (Korea), Vol. 19, Núm. 4, pp. 344-357

  5. Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life

    Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402

  6. Staging Parkinson's disease according to the MNCD classification correlates with caregiver burden

    Brain and Behavior, Vol. 13, Núm. 12

  7. Suicidal ideation among people with Parkinson's disease and comparison with a control group

    International journal of geriatric psychiatry, Vol. 38, Núm. 5, pp. e5919

2022

  1. Epigenetic profiling linked to multisystem inflammatory syndrome in children (MIS-C): A multicenter, retrospective study

    eClinicalMedicine, Vol. 50

  2. Motor Fluctuations Development Is Associated with Non-Mostor Symptoms Burden Progression in Parkinson’s Disease Patients: A 2-Year Follow-Up Study

    Diagnostics, Vol. 12, Núm. 5

  3. Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience

    Cancers, Vol. 14, Núm. 7

2021

  1. Diplopia is frequent and associated with motor and non-motor severity in parkinson’s disease: Results from the COPPADIS cohort at 2-year follow-up

    Diagnostics, Vol. 11, Núm. 12

  2. Epigenome-wide association study of COVID-19 severity with respiratory failure

    EBioMedicine, Vol. 66

  3. Mood in Parkinson's disease: From early- to late-stage disease

    International journal of geriatric psychiatry, Vol. 36, Núm. 5, pp. 627-646

  4. Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson’s disease

    npj Parkinson's Disease, Vol. 7, Núm. 1

  5. Predictors of clinically significant quality of life impairment in Parkinson’s disease

    npj Parkinson's Disease, Vol. 7, Núm. 1

  6. Predictors of global non-motor symptoms burden progression in parkinson’s disease. Results from the coppadis cohort at 2-year follow-up

    Journal of Personalized Medicine, Vol. 11, Núm. 7

  7. Predictors of loss of functional independence in parkinson’s disease: Results from the coppadis cohort at 2-year follow-up and comparison with a control group

    Diagnostics, Vol. 11, Núm. 10

  8. Staging Parkinson’s disease combining motor and nonmotor symptoms correlates with disability and quality of life

    Parkinson's Disease, Vol. 2021

2020

  1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  2. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515